Infective endocarditis (IE) is a life-threatening disease. Its epidemiological profile has substantially changed in recent years although 1-year mortality is still high. Despite advances in medical therapy and surgical technique, there is still uncertainty on the best management and on the timing of surgical intervention. The objective of this review is to produce further insight intothe short- and long-term outcomes of patients with IE, with a focus on those presenting cerebrovascular complications
peer reviewedBACKGROUND: Congenital Heart Disease (CHD) predisposes to Infective Endocarditis (IE),...
The recommendations of the current guidelines and the position papers of professional societies from...
Cardiology Department, State Medical and Pharmaceutical University “Nicolae Testemitanu”, Chisinau,...
SummaryBackground/ObjectiveTo evaluate the clinical results of patients with infective endocarditis ...
Publisher Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland.Background: Infective ...
We sought to provide a contemporary picture of the presentation, etiology, and outcome of infective ...
Journal Article;BACKGROUND The purpose of this study was to assess the incidence of neurological co...
Publisher Copyright: © 2021, The Author(s).Background: Up to 30% or even more of all infective endoc...
Background: Infective endocarditis (IE) is a life-threatening disease. Despite advancements in diagn...
© 2021 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society. Thi...
The last decade has seen many changes in the landscape of infective endocarditis (IE) – ranging from...
ABSTRACT Purpose: This article reviews the current methods of diagnosing and subsequent management o...
This article shows the most recent opinions in the literature, concerning the epidemiology and proph...
PubMed ID: 31187307Infective endocarditis is a growing problem with many shifts due to ever-increasi...
Infective endocarditis (IE) is a rare, life-threatening disease with a mortality rate of upto 25% an...
peer reviewedBACKGROUND: Congenital Heart Disease (CHD) predisposes to Infective Endocarditis (IE),...
The recommendations of the current guidelines and the position papers of professional societies from...
Cardiology Department, State Medical and Pharmaceutical University “Nicolae Testemitanu”, Chisinau,...
SummaryBackground/ObjectiveTo evaluate the clinical results of patients with infective endocarditis ...
Publisher Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland.Background: Infective ...
We sought to provide a contemporary picture of the presentation, etiology, and outcome of infective ...
Journal Article;BACKGROUND The purpose of this study was to assess the incidence of neurological co...
Publisher Copyright: © 2021, The Author(s).Background: Up to 30% or even more of all infective endoc...
Background: Infective endocarditis (IE) is a life-threatening disease. Despite advancements in diagn...
© 2021 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society. Thi...
The last decade has seen many changes in the landscape of infective endocarditis (IE) – ranging from...
ABSTRACT Purpose: This article reviews the current methods of diagnosing and subsequent management o...
This article shows the most recent opinions in the literature, concerning the epidemiology and proph...
PubMed ID: 31187307Infective endocarditis is a growing problem with many shifts due to ever-increasi...
Infective endocarditis (IE) is a rare, life-threatening disease with a mortality rate of upto 25% an...
peer reviewedBACKGROUND: Congenital Heart Disease (CHD) predisposes to Infective Endocarditis (IE),...
The recommendations of the current guidelines and the position papers of professional societies from...
Cardiology Department, State Medical and Pharmaceutical University “Nicolae Testemitanu”, Chisinau,...